These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2884060)

  • 1. Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes.
    Clark A; Matthews DR; Naylor BA; Wells CA; Hosker JP; Turner RC
    Diabetes Res; 1987 Feb; 4(2):51-5. PubMed ID: 2884060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients].
    Li YB; Zhu DL; Tian HM; Shi LX; Luo ZJ; Yan L; Zeng LY; Zhou ZG; Yang LY; Liu J; Li M; Weng JP
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2537-41. PubMed ID: 17198561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.
    Clark A; Wells CA; Buley ID; Cruickshank JK; Vanhegan RI; Matthews DR; Cooper GJ; Holman RR; Turner RC
    Diabetes Res; 1988 Dec; 9(4):151-9. PubMed ID: 3073901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of islet amyloid in type 2 diabetes mellitus.
    Höppener JW; Lips CJ
    Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
    Matveyenko AV; Butler PC
    Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical localisation of caspase-3 in pancreatic islets from type 2 diabetic subjects.
    Tomita T
    Pathology; 2010; 42(5):432-7. PubMed ID: 20632819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
    MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
    Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human type 2 diabetes: morphological evidence for abnormal beta-cell function.
    Sempoux C; Guiot Y; Dubois D; Moulin P; Rahier J
    Diabetes; 2001 Feb; 50 Suppl 1():S172-7. PubMed ID: 11272184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of rat pancreatic islet beta-cell glucose transporter (GLUT 2), proinsulin and islet amyloid polypeptide genes after prolonged fasting, insulin-induced hypoglycaemia and dexamethasone treatment.
    Koranyi L; Bourey R; Turk J; Mueckler M; Permutt MA
    Diabetologia; 1992 Dec; 35(12):1125-32. PubMed ID: 1282477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer.
    Saruc M; Iki K; Pour PM
    Histol Histopathol; 2010 Apr; 25(4):423-32. PubMed ID: 20183795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the defect in pro-hormone processing in Type 2 diabetes mellitus restricted to the beta cell?
    Bano G; Rodin DA; White A; O'Rahilly S; Nussey SS
    Diabet Med; 2001 Jan; 18(1):17-21. PubMed ID: 11168336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.
    Røder ME; Dinesen B; Hartling SG; Houssa P; Vestergaard H; Sodoyez-Goffaux F; Binder C
    Diabetes Care; 1999 Apr; 22(4):609-14. PubMed ID: 10189540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic pathology in non-insulin dependent diabetes (NIDDM).
    Clark A; de Koning EJ; Hattersley AT; Hansen BC; Yajnik CS; Poulton J
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S39-47. PubMed ID: 8529518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.
    Hull RL; Westermark GT; Westermark P; Kahn SE
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3629-43. PubMed ID: 15292279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Banting lecture 1990. Beta-cells in type II diabetes mellitus.
    Porte D
    Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?
    Porte D; Kahn SE
    Diabetes; 1989 Nov; 38(11):1333-6. PubMed ID: 2695369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.